Association of Biomarkers for Dyslipidemia, Inflammation, and Oxidative Stress with Endothelial Dysfunction in Obese Youths: A Case–Control Study
Charu Sharma,Abubaker Suliman,Sania AL Hamad,Javed Yasin,Mohamed Abuzakouk,Juma AlKaabi,Elhadi Aburawi
DOI: https://doi.org/10.2147/dmso.s458233
2024-06-20
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Charu Sharma, 1 Abubaker Suliman, 2 Sania Mazin AL Hamad, 3 Javed Yasin, 1 Mohamed Abuzakouk, 4 Juma AlKaabi, 1 Elhadi Husein Aburawi 3 1 Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, 15551, United Arab Emirates; 2 Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, 15551, United Arab Emirates; 3 Department of Pediatrics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, 15551, United Arab Emirates; 4 Department of Immunology & Allergy, Cleveland Clinic, Abu Dhabi, United Arab Emirates Correspondence: Elhadi Husein Aburawi, Department of Pediatrics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, 15551, United Arab Emirates, Email Objective: The United Arab Emirates (UAE), with its characteristic local population, geography, and history, presents several risk factors for cardiovascular diseases (CVDs) in obese individuals. Obesity and its associated complications, including diabetes, atherogenic dyslipidemia, and CVDs leading to significant health risks. In the present study, "Youths" defined as young people between 18 and 22 years. We assessed dyslipidemia, inflammation, and oxidative stress biomarker levels and their association with endothelial dysfunction (ED) in both overweight/obese and normal weight youths of UAE. Methods: There were 160 youths with overweight/obese (BMI ≥ 25 kg/m 2 ) patients and healthy age- and sex-matched normal weight (BMI ≤ 24.9 kg/m 2 ) as controls participated in this study. The anthropometric data and blood samples were collected to assess the biomarkers for dyslipidemia, inflammation, oxidative stress, ED from all the youths. Results: The overall mean age and male-to-female ratio were 20± 1.5years and 1.0:1.2, respectively. There was statistically significant difference in HDL-C (p< 0.001), triglycerides (TG) (p< 0.001), ApoA (p=0.002), ApoB/ApoA ratio (p=0.009) between the overweight/obese and normal weight youths. Among, inflammatory markers: hs-CRP, IL-6, TNF-α also showed significant p< 0.001 and oxidative stress markers: DNA/RNA Damage, catalase and nitric oxide (NO) showed significant p< 0.001 between groups. Spearman correlation of ED markers with lipid profile markers showed Vitamin C levels positively correlated with HDL-C (p< 0.001) and negatively correlated with glucose (p< 0.001). ICAM-1showed significant negative correlation with HDL-C (p< 0.01) and ApoA (p< 0.001) but positive correlation with TG (p< 0.01) and HbA1c (p< 0.001) among groups. Spearman correlation of ED markers with inflammatory/oxidative stress biomarkers showed Vitamin C levels negatively correlated with ferritin (p < 0.001), NO (p < 0.001), GGT (p < 0.001), and ALT (p < 0.001) levels. The ICAM-1showed significant positive correlation with hs-CRP (p < 0.01), IL-6 (p < 0.001), TNF-α (p < 0.01), GGT (p < 0.05), and ALT (p < 0.05) in both groups. Conclusion: This study revealed a strong link between the biomarkers of dyslipidemia, inflammation, and oxidative stress with ED in overweight/obese patients. This study might be used to predict future cardiovascular events in this population. Keywords: dyslipidemia, inflammation, oxidative stress, endothelial dysfunction, obesity, youth The United Arab Emirates (UAE) and the whole region of the Middle east (ME) are classified as high- and middle-income countries. They have gone through rapid social transformation from rural to urban lifestyle in the last 7 to 8 decades. Coronary artery disease (CAD) occurs at younger age in the ME than all other parts of the world. In the UAE, with its unique local population, geography, and history; numerous risk factors contribute to the development of cardiovascular diseases (CVDs) in obese patients. 1 Obesity is defined as excessive fat deposition that can interfere with the normal metabolic processes. It is a chronic condition associated with various metabolic syndromes, with a rapidly increasing prevalence in children, youths, and adults. 2 Endothelial dysfunction (ED), inflammation, and oxidative stress are early interrelated factors in CVD etiology. 3 Interventions for cardiovascular complications of obesity have proven beneficial in delaying and decreasing the increased risk of morbidity and mortality. Furthermore, targeting controllable factors that contribute most significantly to the global CVD burden, including tobacco use, hypertension, and secondary prevention of CVD, can affect the greatest mortality reduction.<sup -Abstract Truncated-
endocrinology & metabolism